Daiwa Securities Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Buy |
340
+35
| +11% | +$1.24K | ﹤0.01% | 1115 |
|
|
2025
Q1 | $11K | Hold |
305
| – | – | ﹤0.01% | 1090 |
|
|
2024
Q4 | $13K | Sell |
305
-45
| -13% | -$1.92K | ﹤0.01% | 1105 |
|
|
2024
Q3 | $19K | Buy |
350
+46
| +15% | +$2.5K | ﹤0.01% | 1101 |
|
|
2024
Q2 | $12K | Hold |
304
| – | – | ﹤0.01% | 1149 |
|
|
2024
Q1 | $14K | Sell |
304
-32
| -10% | -$1.47K | ﹤0.01% | 1144 |
|
|
2023
Q4 | $16K | Buy |
336
+54
| +19% | +$2.57K | ﹤0.01% | 1137 |
|
|
2023
Q3 | $10K | Hold |
282
| – | – | ﹤0.01% | 1122 |
|
|
2023
Q2 | $13K | Hold |
282
| – | – | ﹤0.01% | 1120 |
|
|
2023
Q1 | $11K | Hold |
282
| – | – | ﹤0.01% | 1098 |
|
|
2022
Q4 | $13K | Buy |
282
+21
| +8% | +$968 | ﹤0.01% | 1097 |
|
|
2022
Q3 | $11K | Hold |
261
| – | – | ﹤0.01% | 1115 |
|
|
2022
Q2 | $16K | Buy |
261
+62
| +31% | +$3.8K | ﹤0.01% | 1113 |
|
|
2022
Q1 | $14K | Hold |
199
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q4 | $17K | Sell |
199
-33
| -14% | -$2.82K | ﹤0.01% | 1118 |
|
|
2021
Q3 | $21K | Buy |
232
+99
| +74% | +$8.96K | ﹤0.01% | 1098 |
|
|
2021
Q2 | $13K | Hold |
133
| – | – | ﹤0.01% | 1030 |
|
|
2021
Q1 | $15K | Buy |
133
+9
| +7% | +$1.02K | ﹤0.01% | 1023 |
|
|
2020
Q4 | $17K | Sell |
124
-216
| -64% | -$29.6K | ﹤0.01% | 987 |
|
|
2020
Q3 | $28K | Buy |
340
+14
| +4% | +$1.15K | ﹤0.01% | 961 |
|
|
2020
Q2 | $14K | Hold |
326
| – | – | ﹤0.01% | 1034 |
|
|
2020
Q1 | $14K | Hold |
326
| – | – | ﹤0.01% | 1026 |
|
|
2019
Q4 | $14K | Sell |
326
-32
| -9% | -$1.37K | ﹤0.01% | 1027 |
|
|
2019
Q3 | $15K | Hold |
358
| – | – | ﹤0.01% | 998 |
|
|
2019
Q2 | $23K | Hold |
358
| – | – | ﹤0.01% | 991 |
|
|
2019
Q1 | $25K | Buy |
358
+98
| +38% | +$6.84K | ﹤0.01% | 974 |
|
|
2018
Q4 | $11K | Hold |
260
| – | – | ﹤0.01% | 984 |
|
|
2018
Q3 | $20K | Hold |
260
| – | – | ﹤0.01% | 991 |
|
|
2018
Q2 | $20K | Hold |
260
| – | – | ﹤0.01% | 1000 |
|
|
2018
Q1 | $13K | Buy |
+260
| New | +$13K | ﹤0.01% | 1003 |
|